AU-rich elements and alternative splicing in the β-catenin 3′UTR can influence the human β-catenin mRNA stability

Experimental Cell Research

Volumn 312, Issue 12, 2006, Pages 2367-2378

  Thiele, Andrea ^a   Nagamine, Yoshikuni ^b   Hauschildt, Sunna ^c   Clevers, Hans ^a  

^a HUBRECHT INSTITUTE   (Netherlands)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

3 UTR; AU rich elements; mRNA; Splicing; Stability; Catenin

Indexed keywords

ADENINE; BETA CATENIN; MESSENGER RNA; NUCLEOTIDE; URIDINE;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ARTICLE; CYTOPLASM; HELA CELL; HUMAN; HUMAN CELL; INTRON; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN STABILITY; RNA STABILITY; TRANSCRIPTION INITIATION;

EID: 33745267217     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.03.029     Document Type: Article

References (40)

1. Ozawa M., Baribault H., and Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8 (1989) 1711-1717
2. Ozawa M., Ringwald M., and Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 4246-4250
3. Behrens J., von Kries J.P., Kuhl M., Bruhn L., Wedlich D., Grosschedl R., and Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382 (1996) 638-642
4. Molenaar M., van de Wetering M., Oosterwegel M., Peterson-Maduro J., Godsave S., Korinek V., Roose J., Destree O., and Clevers H. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86 (1996) 391-399
5. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., Tjon-Pon-Fong M., Moerer P., van den Born M., Soete G., Pals S., Eilers M., Medema R., and Clevers H. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111 (2002) 241-250
6. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., and Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275 (1997) 1784-1787
7. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., and Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 (1997) 1787-1790
8. Polakis P. Wnt signaling and cancer. Genes Dev. 14 (2000) 1837-1851
9. Giles R.H., van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Act. 1653 (2003) 1-24
10. Polakis P. More than one way to skin a catenin. Cell 105 (2001) 563-566
11. Aberle H., Bauer A., Stappert J., Kispert A., and Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16 (1997) 3797-3804
12. Mann B., Gelos M., Siedow A., Hanski M.L., Gratchev A., Ilyas M., Bodmer W.F., Moyer M.P., Riecken E.O., Buhr H.J., and Hanski C. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 1603-1608
13. Ebert M.P., Fei G., Kahmann S., Muller O., Yu J., Sung J.J., and Malfertheiner P. Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 23 (2002) 87-91
14. Huelsken J., Vogel R., Erdmann B., Cotsarelis G., and Birchmeier W. beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105 (2001) 533-545
15. Conne B., Stutz A., and Vassalli J.D. The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology?. Nat. Med. 6 (2000) 637-641
16. Wilusz C.J., Wormington M., and Peltz S.W. The cap-to-tail guide to mRNA turnover. Nat. Rev., Mol. Cell Biol. 2 (2001) 237-246
17. Nollet F., Berx G., Molemans F., and van Roy F. Genomic organization of the human beta-catenin gene (CTNNB1). Genomics 32 (1996) 413-424
18. Roth M.J., Hu N., Johnson L.L., Quon-Hang W., Ahnen D.J., Iwamoto M., Dawsey S.M., Taylor P.R., and Huppi K. b-Catenin splice variants and downstream targets as markers for neoplastic progression of esophageal cancer. Genes Chromosomes Cancer 44 (2005) 423-428
19. Lopez de Silanes I., Fan J., Yang Y., Zonderman A.B., Potapova O., Pizer E.S., and Gorospe M. Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 22 (2003) 7146-7154
20. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., and Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25 (1997) 3389-3402
21. Bowtell D.D. Rapid isolation of eukaryotic DNA. Anal. Biochem. 162 (1987) 463-465
22. In: Sambrock J., Fritzsch E.F., and Maniatis T. (Eds). Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
23. Thiele A., Wasner M., Müller C., Engeland K., and Hauschildt S. Regulation and possible function of beta-catenin in human monocytes. J. Immunol. 167 (2001) 6786-6793
24. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
25. In: Higgins S.J., and Hames B.D. (Eds). RNA Processing: A Practical Approach I (1994), Oxford Univ. Press, Oxford, UK
26. Melton D.A., Krieg P.A., Rebagliati M.R., Maniatis T., Zinn K., and Green M.R. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12 (1984) 7035-7056
27. van de Wetering M., Oving I., Muncan V., Pon Fong M.T., Brantjes H., van Leenen D., Holstege F.C., Brummelkamp T.R., Agami R., and Clevers H. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4 (2003) 609-615
28. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 5547-5551
29. Winzen R., Kracht M., Ritter B., Wilhelm A., Chen C.Y., Shyu A.B., Muller M., Gaestel M., Resch K., and Holtmann H. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18 (1999) 4969-4980
30. Wilson G.M., Sun Y., Sellers J., Lu H., Penkar N., Dillard G., and Brewer G. Regulation of AUF1 expression via conserved alternatively spliced elements in the 3′ untranslated region. Mol. Cell. Biol. 19 (1999) 4056-4064
31. Sureau A., and Perbal B. Several mRNAs with variable 3′ untranslated regions and different stability encode the human PR264/SC35 splicing factor. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 932-936
32. Hentze M.W., and Kulozik A.E. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96 (1999) 307-310
33. Thermann R., Neu-Yilik G., Deters A., Frede U., Wehr K., Hagemeier C., Hentze M.W., and Kulozik A.E. Binary specification of nonsense codons by splicing and cytoplasmic translation. EMBO J. 17 (1998) 3484-3494
34. Sun X., Moriarty P.M., and Maquat L.E. Nonsense-mediated decay of glutathione peroxidase 1 mRNA in the cytoplasm depends on intron position. EMBO J. 19 (2000) 4734-4744
35. Chen C.Y., and Shyu A.B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20 (1995) 465-470
36. Chen C.Y., Xu N., and Shyu A.B. Highly selective actions of HuR in antagonizing AU-rich element-mediated mRNA destabilization. Mol. Cell. Biol. 22 (2002) 7268-7278
37. Myer V.E., Fan X.C., and Steitz J.A. Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J. 16 (1997) 2130-2139
38. Nabors L.B., Gillespie G.Y., Harkins L., and King P.H. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res. 61 (2001) 2154-2161
39. Denkert C., Weichert W., Winzer K.J., Muller B.M., Noske A., Niesporek S., Kristiansen G., Guski H., Dietel M., and Hauptmann S. Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin. Cancer Res. 10 (2004) 5580-5586
40. Rasmussen H.B., Kelly M.A., and Clausen J. Genetic susceptibility to multiple sclerosis: detection of polymorphic nucleotides and an intron in the 3′ untranslated region of the major histocompatibility complex class II transactivator gene. Hum. Immunol. 62 (2001) 371-377